Coloplast
435,50 DKK
-0,09 %
Mindre end 1K følgere
COLO B
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Værdiansættelse
Resultatopgørelse
Kvartalsdata
Resultatopgørelse
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Coloplast
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Omsætning | 17.939,0 | 18.544,0 | 19.426,0 | 22.579,0 | 24.500,0 | 27.030,0 | 27.874,0 |
| vækst-% | 3,4 % | 4,8 % | 16,2 % | 8,5 % | 10,3 % | 3,1 % | |
| EBITDA | 5.807,0 | 6.705,0 | 6.947,0 | 7.369,0 | 7.840,0 | 8.610,0 | 9.123,0 |
| EBIT | 5.156,0 | 5.854,0 | 6.155,0 | 6.439,0 | 6.771,0 | 7.320,0 | 7.201,0 |
| Overskud før skat | 5.028,0 | 5.466,0 | 6.233,0 | 6.127,0 | 6.025,0 | 6.395,0 | 6.157,0 |
| Netto indkomst | 3.873,0 | 4.197,0 | 4.825,0 | 4.706,0 | 4.783,0 | 5.052,0 | 3.636,0 |
| EPS | 18,32 | 19,86 | 22,83 | 22,14 | 22,21 | 22,46 | 16,13 |
| Udbytte | 17,00 | 18,00 | 19,00 | 20,00 | 21,00 | 22,00 | 18,00 |
| Udbytte ratio | 92,8 % | 90,6 % | 83,2 % | 90,3 % | 94,6 % | 98,0 % | 111,6 % |
Lønsomhed og afkast på kapital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 32,4 % | 36,2 % | 35,8 % | 32,6 % | 32,0 % | 31,9 % | 32,7 % |
| EBIT-% | 28,7 % | 31,6 % | 31,7 % | 28,5 % | 27,6 % | 27,1 % | 25,8 % |
| ROE | 56,0 % | 56,7 % | 59,1 % | 56,8 % | 27,6 % | 28,2 % | 22,6 % |
| ROI | 30,4 % | 31,1 % | 30,5 % | 13,5 % | 9,9 % | 10,5 % | 7,5 % |